Tekla Capital Management LLC - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 327 filers reported holding NOVOCURE LTD in Q1 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.

Quarter-by-quarter ownership
Tekla Capital Management LLC ownership history of NOVOCURE LTD
ValueSharesWeighting
Q4 2020$15,213,000
+17.0%
87,918
-24.8%
0.54%
+9.9%
Q3 2020$13,006,000
+66.6%
116,845
-11.2%
0.49%
+64.0%
Q2 2020$7,806,000
+7.9%
131,637
+22.5%
0.30%
-9.2%
Q1 2020$7,235,000
-20.1%
107,4380.0%0.33%
-4.4%
Q4 2019$9,054,000
+20.0%
107,438
+6.4%
0.34%
+4.0%
Q3 2019$7,548,000
+120.8%
100,932
+86.7%
0.33%
+135.0%
Q2 2019$3,419,000
+7.6%
54,074
-18.0%
0.14%
+8.5%
Q1 2019$3,177,000
+287.4%
65,964
+169.2%
0.13%
+268.6%
Q4 2018$820,00024,5000.04%
Other shareholders
NOVOCURE LTD shareholders Q1 2021
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 470,884$27,923,00010.09%
Darsana Capital Partners LP 1,700,000$100,810,0005.98%
HARTLINE INVESTMENT CORP/ 336,617$19,961,0004.18%
Rhenman & Partners Asset Management AB 375,000$22,238,0002.40%
MORGAN JESS S & CO INC 35,942$2,131,0002.31%
Soleus Capital Management, L.P. 56,397$3,344,0001.91%
Bullseye Asset Management LLC 45,161$2,678,0001.43%
Taylor Frigon Capital Management LLC 46,304$2,746,0001.36%
COURAGE CAPITAL MANAGEMENT LLC 10,000$593,0001.09%
Redwood Investments, LLC 192,986$11,444,0001.01%
View complete list of NOVOCURE LTD shareholders